0001140361-14-046793.txt : 20141231 0001140361-14-046793.hdr.sgml : 20141231 20141231125304 ACCESSION NUMBER: 0001140361-14-046793 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141231 DATE AS OF CHANGE: 20141231 EFFECTIVENESS DATE: 20141231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HDL THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001569047 IRS NUMBER: 273015978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231219 FILM NUMBER: 141318020 BUSINESS ADDRESS: STREET 1: 601 21ST STREET STREET 2: SUITE 300 CITY: VERO BEACH STATE: FL ZIP: 32960 BUSINESS PHONE: 203-464-2890 MAIL ADDRESS: STREET 1: 601 21ST STREET STREET 2: SUITE 300 CITY: VERO BEACH STATE: FL ZIP: 32960 D 1 primary_doc.xml X0707 D LIVE 0001569047 HDL THERAPEUTICS, INC. 601 21st Street Suite 300 Vero Beach FL FLORIDA 32960 203-464-2890 DELAWARE None None Corporation true 2013 Michael Matin c/o HDL Therapeutics, Inc. 601 21st Street, Suite 300 Vero Beach FL FLORIDA 32960 Executive Officer Director Mr. Matin is the Chief Executive Officer and Secretary of the Issuer. Bryan Brewer c/o HDL Therapeutics, Inc. 601 21st Street, Suite 300 Vero Beach FL FLORIDA 32960 Executive Officer Director Dr. Brewer is the Chief Scientific Officer of the Issuer. Biotechnology Decline to Disclose 06b false 2014-05-02 true true true Series B Preferred Stock false 0 4576660 2045000 2531660 true 0 14 0 0 500000 true false HDL THERAPEUTICS, INC. /s/ Michael Matin Michael Matin Chief Executive Officer 2014-12-31